Detecting the Patient at Risk of Heart Failure

Journal of the American College of Cardiology

Volumn 55, Issue 19, 2010, Pages 2138-2139

  Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

elderly; heart failure; inflammation

Indexed keywords

INTERLEUKIN 6;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE MARKER; EDITORIAL; HEART EJECTION FRACTION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; PREDICTION; PRIORITY JOURNAL; SCREENING;

AGE FACTORS; BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; INCIDENCE; INTERLEUKIN-6; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77951624617     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.035     Document Type: Editorial

References (10)

1. Kalogeropoulos A., Georgiopoulou V., Psaty B.M., et al., Health ABC Study Investigators. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) Study. J Am Coll Cardiol 55 (2010) 2129-2137
2. Butler J., Kalogeropoulos A., Georgiopoulou V., et al. Incident heart failure prediction in the elderly: the Health ABC Heart Failure Score. Circ Heart Fail 1 (2008) 125-133
3. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
4. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-e82
5. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
6. The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375 (2010) 132-140
7. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
8. Duprez D.A., and Cohn J.N. Time to foster a rational approach to preventing cardiovascular morbid events. J Am Coll Cardiol 52 (2008) 327-329
9. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (1992) 685-691
10. Duprez D.A., Florea N.D., Jones K., and Cohn J.N. Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study. J Am Coll Cardiol 50 (2007) 835-839